Articles for the ‘’ Category

The intersection of pharmaceutical advertising, consumer protection, and internal market freedoms remains a complex legal battleground within the EU. In Apothekerkammer Nordrhein v. DocMorris NV (C-517/23), the Court of Justice of the European Union (CJEU) revisited the meaning of ‘advertising of medicinal products’, clarifying how far national restrictions on pharmaceutical advertisements can go under EU pharmaceutical law and internal market principles.

Informing healthcare professionals about the latest findings from studies related to medicinal products is crucial for ensuring effective and safe patient care. Access to the most recent scientific knowledge allows physicians to better understand the effects and potential side effects of medications, leading to more informed prescribing decisions.